Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in MYGN — Myriad Genetics Inc

CIK 1729829 LONDON, X0
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,511,917
+$1,904,843 QoQ
Shares Held
1,665,835
-1.5% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 196 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $925,783,255 across 15 Diagnostics & Research names. MYGN ranks #12 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 492,580 $246,959,908
2 A
Agilent Technologies, Inc.
 1,415,364 $188,002,800
3 DHR
Danaher Corp /De/
 844,514 $160,863,026
4 IDXX
Idexx Laboratories Inc /De
 148,395 $78,121,063
5 DGX
Quest Diagnostics Inc
 343,398 $72,783,206
6 IQV
Iqvia Holdings Inc.
 279,086 $53,924,996
7 NTRA
Natera, Inc.
 161,079 $43,724,894
8 GH
Guardant Health, Inc.
 156,236 $23,440,087

All Filings in MYGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,511,917 1,665,835
2026-03-31 $7,607,074 1,690,461
2025-12-31 $5,369,724 873,126
2025-09-30 $8,578,445 1,186,507
2025-06-30 $10,893,932 2,051,588
2025-03-31 $12,578,981 1,418,149
2024-12-31 $13,728,823 1,001,373
2024-09-30 $13,931,211 508,624
2024-06-30 $1,731,204 70,777
2023-12-31 $364,999 19,070
2023-09-30 $2,110,110 131,553
2023-06-30 $430,058 18,553
2022-06-30 $327,514 18,025